X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 100 filers reported holding X4 PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,809,775 | -14.4% | 6,247,500 | +52.4% | 2.18% | -26.4% |
| Q2 2023 | $7,953,889 | +135.7% | 4,099,943 | +5.7% | 2.96% | +187.5% |
| Q1 2023 | $3,374,281 | -8.3% | 3,878,484 | +4.6% | 1.03% | -31.0% |
| Q4 2022 | $3,681,000 | -14.0% | 3,706,517 | +48.0% | 1.49% | +26.7% |
| Q3 2022 | $4,282,000 | +155.3% | 2,504,006 | +44.0% | 1.18% | +71.0% |
| Q2 2022 | $1,677,000 | -44.2% | 1,738,300 | +1.2% | 0.69% | -41.5% |
| Q1 2022 | $3,006,000 | -16.9% | 1,717,589 | +8.8% | 1.17% | -17.6% |
| Q4 2021 | $3,616,000 | – | 1,578,947 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 2,300,315 | $4,462,611 | 4.69% |
| Stonepine Capital Management, LLC | 4,605,263 | $8,934,210 | 3.22% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $30,963,541 | 3.19% |
| Tri Locum Partners LP | 4,099,943 | $7,953,889 | 2.96% |
| NEA Management Company, LLC | 14,986,793 | $29,074,378 | 2.22% |
| Lynwood Capital Management Inc. | 525,000 | $1,018,500 | 1.29% |
| Parkman Healthcare Partners LLC | 3,766,593 | $7,307,190 | 1.27% |
| Sio Capital Management, LLC | 1,749,003 | $3,393,066 | 0.86% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $649,900 | 0.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $3,828,945 | 0.36% |